According to Viridian Therapeutics's latest financial reports the company's current EPS (TTM) is -4,67ย โฌ. In 2022 the company made an earnings per share (EPS) of -3,86ย โฌ an increase over its 2021 EPS that were of -7,26ย โฌ.